|1.||Kulirankal, Kiran: 1 article (01/2014)|
|2.||Basheer, Aneesh: 1 article (01/2014)|
|3.||Shanmugham, Vijay: 1 article (01/2014)|
|4.||Natarajan, Nagarajan: 1 article (01/2014)|
|5.||Mookkappan, Sudhagar: 1 article (01/2014)|
|6.||Viswanathan, Stalin: 1 article (01/2013)|
|7.||Salunke, Rajani: 1 article (04/2012)|
|8.||Gupta, Bina: 1 article (04/2012)|
|9.||Kumar, Rahul: 1 article (04/2012)|
|10.||Rani, Manviri: 1 article (04/2012)|
01/01/2014 - "Only one case of black colored urine following quinalphos poisoning has been reported in literature. "
01/01/2013 - "Unusual complications of quinalphos poisoning."
06/01/1993 - "Administration of 0.75, 1.50 or 3.0 mg/kg/d technical quinalphos for 90 d po to rats produced poisoning and death. "
01/01/1983 - "[Accidental subacute severe poisoning with the pesticide Ekalux 25 through injured skin in childhood]."
09/01/1993 - "Quinalphos was slowly absorbed from the gastrointestinal tract, as indicated by the severity of the cholinergic symptoms and the inhibition of neuropathy target esterase, which reached its maximum 72 and 96 h after poisoning. "
|2.||Body Weight (Weight, Body)
04/30/2012 - "The metabolic intermediates of quinalphos in serum and urine of albino rats at different time intervals were identified after dosing the animals with 5 mg kg(-1) body weight. "
07/01/2003 - "Testicular and spermatotoxic effects were investigated in rats exposed to technical-grade quinalphos (70%) at dose levels of 0.52 mg kg(-1) (1/50th ld(50)) or 1.04 mg kg(-1) body weight (1/25th ld(50)) for 5 days a week for 60 days. "
01/01/2000 - "Long-term animal bioassays conducted for the evaluation of complete carcinogenic, tumour-initiating and tumour-promoting potential of Quinalphos revealed that it has only tumour-initiating potential at a dose of 10 mg/kg body weight (b.wt.), in the two-stage mouse skin model of carcinogenesis. "
06/01/1999 - "Hence, 2 mg/kg body weight of quinalphos could be considered as the no-observed-effect level (NOEL) on foetal and maternal toxicity in rats."
06/01/1999 - "Technical quinalphos (0.5, 1.5, 2, 3 or 4.5 mg/kg body weight) was administered orally to pregnant rats from day 6-15 of gestation. "
|3.||Chromosome Aberrations (Chromosome Abnormalities)
11/01/1990 - "2. A significant increase in chromosomal aberrations was observed when cells were treated with quinalphos for 48 and 72 h and a significant increase in SCEs was observed at all the concentrations and over all the time periods. "
11/10/2005 - "In vivo cytogenetic effects of commercially formulated cypermethrin (CYP, synthetic pyrethroid insecticide) and/or quinalphos (QUI, organophosphate insecticide), generally used in combination, were examined through chromosomal aberrations (CA) and micronucleus test (MT) in mice. "
11/01/1990 - "1. Four different concentrations of quinalphos and methyl parathion were tested on human peripheral lymphocytes over different time periods, for the analysis of chromosomal aberrations and sister chromatid exchanges (SCEs). "
02/01/1991 - "Quinalphos induced micronuclei in the bone-marrow cells of mice and also caused a significant increase in chromosomal aberrations in bone-marrow cells (at 10 and 15 mg/kg body weight dose levels) and in germ cells (at all tested doses). "
|4.||Phototoxic Dermatitis (Phototoxicity)
|5.||Hepatocellular Carcinoma (Hepatoma)
|7.||Methyl Parathion (Dalf)
|9.||Dihydrotachysterol (AT 10)